Article info
PDFLetter
Tumour necrosis factor blockade mediates altered serotonin transporter availability in rheumatoid arthritis: a clinical, proof-of-concept study
- Correspondence to Dr Jonathan Cavanagh, Sackler Institute of Psychobiological Research, Faculty of Medicine University of Glasgow, Southern General Hospital, Glasgow G51 4TF, UK; Jonathan.Cavanagh{at}clinmed.gla.ac.uk
Citation
Tumour necrosis factor blockade mediates altered serotonin transporter availability in rheumatoid arthritis: a clinical, proof-of-concept study
Publication history
- Accepted June 27, 2009
- First published April 6, 2010.
Online issue publication
October 31, 2019
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions